Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Stevanato Group SpASTU:87N 88 Debt-to-EBITDA is 2.81 as of Jun. 2026, which is 70% above its 10-year median of 1.65. GuruFocus rates STU:87N with a GF Score™ of 88/100 and a GF Value™ of €22.17 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 471 Medical Devices & Instruments companies, Stevanato Group SpA ranks worse than 53.5% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Stevanato Group SpA's Debt-to-EBITDA or its related term are showing as below:
STU:87N'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.85 Med: 1.65 Max: 3.53
Current: 1.78
During the past 8 years, the highest Debt-to-EBITDA Ratio of Stevanato Group SpA was 3.53. The lowest was 0.85. And the median was 1.65.
STU:87N's Debt-to-EBITDA is ranked worse than 53.5% of 471
companies
in the Medical Devices & Instruments industry
Industry Median: 1.63
vs STU:87N: 1.78
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Stevanato Group SpA Debt-to-EBITDA Related Terms
Stevanato Group SpA Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Stevanato Group SpA's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:87N vs MMED, TFX, MMSI: Debt-to-EBITDA Comparison
For the Medical Instruments & Supplies subindustry, Stevanato Group SpA's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Stevanato Group SpA Debt-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Stevanato Group SpA's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Stevanato Group SpA's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Jun. 2026) EBITDA data.
Stevanato Group SpA (STU:87N) has a Debt-to-EBITDA of 2.81 as of Jun. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Stevanato Group SpA. This is 70% above median its historical median of 1.65. Over the past decade, Stevanato Group SpA's Debt-to-EBITDA has ranged from 0.85 to 3.53. According to the industry distribution chart, Stevanato Group SpA ranks #252 out of 471 companies in the Medical Devices & Instruments industry, placing it in the top 53.5%.
Is Stevanato Group SpA's Debt-to-EBITDA too high?
Stevanato Group SpA's current Debt-to-EBITDA of 2.81 is 70% above median its 10-year median of 1.65. Over the past 10 years, this metric has ranged from a low of 0.85 to a high of 3.53. The Medical Devices & Instruments industry median Debt-to-EBITDA is 1.63. Stevanato Group SpA's value of 2.81 is 72.4% above this industry median. Based on the distribution chart, Stevanato Group SpA ranks #252 out of 471 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Stevanato Group SpA has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Stevanato Group SpA's Debt-to-EBITDA compare to MMED and TFX?
According to the Medical Devices & Instruments industry distribution chart, Stevanato Group SpA ranks #252 out of 471 companies for Debt-to-EBITDA. This places Stevanato Group SpA in the lower half of its industry. The industry median Debt-to-EBITDA is 1.63. Stevanato Group SpA's value of 2.81 is 72.4% above this benchmark. Historically, Stevanato Group SpA's own Debt-to-EBITDA has ranged from 0.85 to 3.53 over the past decade. While the company's 10-year median is 1.65 vs. the industry median of 1.63, Stevanato Group SpA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Medical Devices & Instruments company?
The median Debt-to-EBITDA among Medical Devices & Instruments companies is 1.63, based on 471 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Stevanato Group SpA's current Debt-to-EBITDA of 2.81 is 72.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Stevanato Group SpA. For the Medical Devices & Instruments industry, the median Debt-to-EBITDA is 1.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Stevanato Group SpA's current Debt-to-EBITDA is 2.81, which is 70% above median its own 10-year median of 1.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stevanato Group SpA stock overvalued right now?
Based on GuruFocus' analysis, Stevanato Group SpA (STU:87N) is currently considered Modestly Undervalued. The stock's GF Value™ is €22.17, compared to a current price of €17.30 — trading 22% below its estimated fair value. The current Debt-to-EBITDA is 2.81, which is 70% above median its 10-year median of 1.65 and 72.4% above the Medical Devices & Instruments industry median of 1.63. Stevanato Group SpA's overall GF Score™ is 88/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Stevanato Group SpA (STU:87N), the current Debt-to-EBITDA is 2.81 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Stevanato Group SpA (STU:87N) Overvalued in 2026?
Based on GuruFocus' analysis, Stevanato Group SpA stock appears to be undervalued.
The current stock price of €17.30 is trading 22% below its estimated GF Value™ of €22.17.
GuruFocus considers Stevanato Group SpA to be Modestly Undervalued.
Key valuation signals for STU:87N:
Debt-to-EBITDA: 2.81 (70% above median its 10-year median of 1.65)
GF Value™: €22.17 vs. price of €17.30 (22% below fair value)
Industry Position: 72.4% above the Medical Devices & Instruments median (#252 of 471)
No single metric tells the full story. See the STU:87N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.
88GF Score
Get the complete analysis for STU:87N
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:87N has been successfully added to your 
